NMPA Approval

Roxatidine Acetate Hydrochloride For Injection

Approval Number

国药准字H20233994

Company扬子江药业集团江苏紫龙药业有限公司

Registration Date

August 1, 2023

Drug Information

Generic Name

注射用盐酸罗沙替丁醋酸酯

Dosage Form

注射剂

Strength

75mg（按C ₁₉H₂₈N₂O₄•HCl计）

Drug Type

化学药品

Registration Date

August 1, 2023

Company Information

Applicant Company

Company Name扬子江药业集团江苏紫龙药业有限公司

Company Address

常州市新北区薛家镇云河西路9号

Manufacturing Company

Company Name扬子江药业集团江苏紫龙药业有限公司

Company Address

江苏省常州市新北区薛家镇云河西路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸罗沙替丁醋酸酯 - NMPA 批准文号 | MedPath